Advanced Materials Technologies,
Journal Year:
2023,
Volume and Issue:
8(10)
Published: Jan. 31, 2023
Abstract
Rapid
screening
of
individuals
infected
with
severe
acute
respiratory
syndrome‐coronavirus‐2
(SARS‐CoV‐2)
is
necessary
to
contain
contagion
in
a
large
population.
Nucleic
acid‐based
gold
standard
assays
are
time‐consuming,
and
nucleic
acid
amplification
mandatory
expensive,
impeding
the
containment
coronavirus
disease
2019
(COVID‐19)
outbreak.
To
overcome
aforementioned
disadvantages,
this
study
deals
specially
designed
(Au)‐deoxyribonucleic
(DNA)‐cadmium
telluride
(CdTe)
quantum
dot
(QD)
probe
target
two
sections
nucleocapsid
(N)
gene
SARS‐CoV‐2
ribonucleic
(RNA)
three
variants
(B.1.1.529,
B.1.617.2,
B.1.351).
A
duplex‐specific
nuclease
(DSN)‐assisted
highly
selective
release
signaling
probes
enable
higher
specificity,
an
Au‐supported
DNA
incorporated
carry
many
CdTe
QD
probes.
After
dissolution,
generated
Cd
2+
ions
quantified
at
novel
cobalt
sulfide
(CoS)‐nitrogen‐doped
graphene
(NGQD)/platinum
(Pt)@palladium
(Pd)
electrode
extraordinary
sensitivity
through
square
wave
anodic
stripping
voltammetry
(SWASV).
The
developed
sensor
exhibits
wide
range
detection
(10
10
8
copies
µL
−1
)
lower
limit
(0.12
),
without
any
amplification.
selectivity
tested
against
MERS
HCoV‐NL63,
real‐time
performed
on
heat‐inactivated
viral
samples,
which
show
excellent
selectivity.
Chemosensors,
Journal Year:
2022,
Volume and Issue:
10(11), P. 459 - 459
Published: Nov. 5, 2022
COVID-19
caused
by
a
SARS-CoV-2
infection
was
first
reported
from
Wuhan,
China,
and
later
recognized
as
pandemic
on
March
11,
2020,
the
World
Health
Organization
(WHO).
Gold
standard
nucleic
acid
molecular-based
testing
have
largely
satisfied
requirements
of
early
diagnosis
management
this
infectious
disease;
however,
these
techniques
are
expensive
not
readily
available
for
point-of-care
(POC)
applications.
The
21st
century
has
emphasized
that
medicine
is
in
dire
need
advanced,
rapid,
cheap
diagnostic
tools.
Herein,
we
report
molecularly
imprinted
polymer
nanoparticles
(MIP-NPs/nanoMIPs)
plastic
antibodies
specific
detection
employing
surface
plasmon
resonance
(SPR)
sensor.
High-affinity
MIP-NPs
directed
against
were
manufactured
using
solid-phase
imprinting
method.
then
characterized
dynamic
light
scattering
(DLS)
atomic
force
microscopy
(AFM)
prior
to
their
incorporation
into
label-free
portable
SPR
device.
Detection
studied
within
range
104–106
PFU
mL−1.
demonstrated
good
binding
affinity
(KD
=
0.12
pM)
selectivity
toward
SARS-CoV-2.
AFM,
cyclic
voltammetry,
square-wave
voltammetry
studies
revealed
successful
stepwise
preparation
A
cross-reactivity
test
confirmed
specificity
For
time,
study
demonstrates
potential
molecular
technology
conjunction
with
miniaturized
devices
particles
high-affinity
specificity.
Such
sensors
could
help
monitor
manage
risks
related
virus
contamination
infections
also
beyond
current
pandemic.
Advanced Materials Technologies,
Journal Year:
2023,
Volume and Issue:
8(11)
Published: April 4, 2023
Abstract
The
SARS‐CoV‐2
pandemic
caused
a
public
health
crisis
throughout
the
world
and
highlighted
need
for
rapid
sensitive
testing
as
countermeasure.
A
specific
biosensor
platform
is
developed
detection
of
antigen
RNA
SARS‐CoV‐2,
its
variant
(B1.1.529).
demonstrated
combines
unique
protein
catalyzed
capture
bioreceptors
(PCCs)
chimeric
(RNA‐DNA)
probe
using
LwaCas13a
collateral
cleavage
activity
atop
graphene
field
effect
transistors
(gFETs).
reported
able
to
differentiate
unprocessed
10
4
pfu
m
−1
samples
from
Influenza
Rhinovirus.
limit
(LOD)
calculated
3
in
buffer
PFU
mL
10%
saliva,
while
LOD
≈65
viral
isolate
without
amplification.
To
provide
high
reliability
detection,
role
internal
external
factors
with
respect
gate
voltage
further
analyzed
by
Principal
Component
Analysis
(PCA).
Based
on
PCA
analysis,
authors
are
classify
pathogen
positive
or
negative
(
Y
>
0:
Positive
pathogen,
<
Negative
pathogen).
can
be
quickly
adapted
multi‐omics
multiplexed
diagnosis
continuously
evolving
biothreats
global
pandemics.
Nano Convergence,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: Jan. 11, 2024
Abstract
The
unprecedented
threat
of
the
highly
contagious
virus,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
causes
exponentially
increased
infections
disease
2019
(COVID-19),
highlights
weak
spots
current
diagnostic
toolbox.
In
midst
catastrophe,
nanobiosensors
offer
a
new
opportunity
as
an
alternative
tool
to
fill
gap
among
molecular
tests,
rapid
antigen
and
serological
tests.
Nanobiosensors
surpass
potential
tests
because
their
enhanced
sensitivity,
thus
enabling
us
see
antigens
stable
easy-to-access
targets.
During
first
three
years
COVID-19
pandemic,
substantial
number
studies
have
reported
for
detection
SARS-CoV-2
antigens.
articles
on
exceeds
amount
nanobiosensor
research
detecting
previous
infectious
diseases,
from
influenza
SARS-CoV
MERS-CoV.
This
publishing
pace
also
implies
significance
present
pandemic.
this
review,
158
reporting
are
collected
discuss
challenges
using
criteria
point-of-care
(POC)
diagnostics
along
with
COVID-specific
issues.
These
advances
lessons
during
pandemic
pave
way
preparing
post-COVID
era
upcoming
diseases.
Graphical
Applied Physics Reviews,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: Jan. 26, 2024
Graphene-based
materials
and
DNA
probes/nanostructures
have
emerged
as
building
blocks
for
constructing
powerful
biosensors.
possess
exceptional
properties,
including
two-dimensional
atomically
flat
basal
planes
biomolecule
binding.
probes
serve
excellent
selective
probes,
exhibiting
specific
recognition
capabilities
toward
diverse
target
analytes.
Meanwhile,
nanostructures
function
placement
scaffolds,
enabling
the
precise
organization
of
molecular
species
at
nanoscale
positioning
complex
biomolecular
assays.
The
interplay
graphene-based
has
fostered
creation
intricate
hybrid
with
user-defined
architectures.
This
advancement
resulted
in
significant
progress
developing
novel
biosensors
detecting
DNA,
RNA,
small
molecules,
proteins,
well
sequencing.
Consequently,
a
profound
understanding
interactions
between
is
key
to
these
biological
devices.
In
this
review,
we
systematically
discussed
current
comprehension
interaction
materials,
elucidated
latest
advancements
probe–graphene-based
Additionally,
concisely
summarized
recent
research
endeavors
involving
deposition
on
explored
imminent
biosensing
applications
by
seamlessly
integrating
materials.
Finally,
delineated
primary
challenges
provided
prospective
insights
into
rapidly
field.
We
envision
that
review
will
aid
researchers
gaining
deeper
insight
mechanisms
DNA–graphene-based
biosensors,
designing
desired
applications.
Nanotechnology,
Journal Year:
2023,
Volume and Issue:
34(49), P. 492002 - 492002
Published: Aug. 25, 2023
The
future
of
medical
diagnostics
calls
for
portable
biosensors
at
the
point
care,
aiming
to
improve
healthcare
by
reducing
costs,
improving
access,
and
increasing
quality-what
is
called
'triple
aim'.
Developing
point-of-care
sensors
that
provide
high
sensitivity,
detect
multiple
analytes,
real
time
measurements
can
expand
access
all.
Field-effect
transistor
(FET)-based
have
several
advantages,
including
ultrahigh
label-free
amplification-free
detection,
reduced
cost
complexity,
portability,
large-scale
multiplexing.
They
also
be
integrated
into
wearable
or
implantable
devices
continuous,
real-time
monitoring
analytesin
vivo,
enabling
early
detection
biomarkers
disease
diagnosis
management.
This
review
analyzes
advances
in
parallelization,
reusability
FET
biosensors,
benchmarks
limit
state
art,
discusses
challenges
opportunities
applications.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(47)
Published: Nov. 13, 2023
Dementia
is
a
brain
disease
which
results
in
irreversible
and
progressive
loss
of
cognition
motor
activity.
Despite
global
efforts,
there
no
simple
reliable
diagnosis
or
treatment
option.
Current
involves
indirect
testing
commonly
inaccessible
biofluids
low-resolution
imaging.
We
have
developed
portable,
wireless
readout-based
Graphene
field-effect
transistor
(GFET)
biosensor
platform
that
can
detect
viruses,
proteins,
small
molecules
with
single-molecule
sensitivity
specificity.
report
the
detection
three
important
amyloids,
namely,
Amyloid
beta
(Aβ),
Tau
(τ),
α-Synuclein
(αS)
using
DNA
aptamer
nanoprobes.
These
amyloids
were
isolated,
purified,
characterized
from
autopsied
tissues
Alzheimer’s
Disease
(AD)
Parkinson’s
(PD)
patients.
The
limit
(LoD)
sensor
10
fM,
1–10
pM,
10–100
fM
for
Aβ,
τ,
αS,
respectively.
Synthetic
as
well
brain-derived
showed
statistically
significant
response
respect
to
derived
thresholds,
confirming
ability
define
diseased
vs.
nondiseased
states.
each
amyloid
was
specific
their
aptamers;
αS
peptides
when
tested,
respectively,
aptamers
nonspecific
them
insignificant
cross-reactivity.
Thus,
aptamer-based
GFET
has
high
precision
across
range
epidemiologically
AD
PD
variants.
This
portable
diagnostic
system
would
allow
at-home
POC
neurodegenerative
diseases
globally.
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 17, 2024
Abstract
The
burgeoning
demand
for
healthcare
monitoring
has
brought
field
effect
transistor
(FET)
biosensors
into
the
spotlight
as
a
highly
efficient
detection
technology.
FET
offer
inherent
advantages
including
high
sensitivity,
rapid
response
times,
operational
simplicity,
integrability,
and
label‐free
detection.
These
characteristics
render
them
particularly
well‐suited
detecting
diverse
array
of
physiological
parameters
biomarkers,
thereby
furnishing
real‐time
data
crucial
personalized
medicine
disease
prevention.
This
review
aims
to
elucidate
recent
advancements
in
within
realm
management
encompassing
several
facets.
Initially,
this
systematically
analyzes
device
architecture,
sensing
mechanisms,
performance
evaluation
methods
gain
an
in‐depth
understanding
their
principles
features.
Subsequently,
it
focuses
on
application
health‐related
biomarkers
nucleic
acids,
proteins,
exosomes,
viruses,
etc.
Lastly,
presents
engineered
medical
sensor
prototypes
predicated
biosensors,
such
point‐of‐care
testing
devices,
wearable
sensors,
implantable
underscoring
practical
utility
potential
health
management.
In
addition,
addresses
critical
issues
prospects
using
monitoring,
aiming
provide
some
references
insights
research
innovation
field.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 23, 2025
Proteins
have
been
one
of
the
most
important
biomarkers
for
diagnosing
diseases,
and
field-effect
transistor
(FET)
biosensors
possess
high
sensitivity;
are
label-free;
feature
real-time
detection,
rapidity,
easy
integration
protein
detection.
FET
mainly
made
up
parts,
such
as
channel
materials,
bio
receptors.
This
Tutorial
provides
an
in-depth
exploration
detection
from
composition
perspective
discusses
commercialization
point-of-care
diagnostics
proteins
based
on
biosensors.